Chen X - Search Results

1

Development and characterization of 5 canine B-cell lymphoma cell lines.

Zwingenberger AL, Vernau W, Shi C, Yan W, Chen X, Gordon IK, Kent MS. Zwingenberger AL, et al. Among authors: chen x. Leuk Res. 2012 May;36(5):601-6. doi: 10.1016/j.leukres.2011.11.004. Epub 2011 Dec 1. Leuk Res. 2012. PMID: 22136758 Free PMC article.

2

GPX2, a direct target of p63, inhibits oxidative stress-induced apoptosis in a p53-dependent manner.

Yan W, Chen X. Yan W, et al. Among authors: chen x. J Biol Chem. 2006 Mar 24;281(12):7856-62. doi: 10.1074/jbc.M512655200. Epub 2006 Jan 30. J Biol Chem. 2006. PMID: 16446369 Free article.

3

RNPC1, an RNA-binding protein and a target of the p53 family, is required for maintaining the stability of the basal and stress-induced p21 transcript.

Shu L, Yan W, Chen X. Shu L, et al. Among authors: chen x. Genes Dev. 2006 Nov 1;20(21):2961-72. doi: 10.1101/gad.1463306. Epub 2006 Oct 18. Genes Dev. 2006. PMID: 17050675 Free PMC article.

4

Myocardial smad4 is essential for cardiogenesis in mouse embryos.

Song L, Yan W, Chen X, Deng CX, Wang Q, Jiao K. Song L, et al. Among authors: chen x. Circ Res. 2007 Aug 3;101(3):277-85. doi: 10.1161/CIRCRESAHA.107.155630. Epub 2007 Jun 21. Circ Res. 2007. PMID: 17585069 Free PMC article.

5

Targeted repression of bone morphogenetic protein 7, a novel target of the p53 family, triggers proliferative defect in p53-deficient breast cancer cells.

Yan W, Chen X. Yan W, et al. Among authors: chen x. Cancer Res. 2007 Oct 1;67(19):9117-24. doi: 10.1158/0008-5472.CAN-07-0996. Cancer Res. 2007. PMID: 17909016

6

Suppression of inhibitor of differentiation 2, a target of mutant p53, is required for gain-of-function mutations.

Yan W, Liu G, Scoumanne A, Chen X. Yan W, et al. Among authors: chen x. Cancer Res. 2008 Aug 15;68(16):6789-96. doi: 10.1158/0008-5472.CAN-08-0810. Cancer Res. 2008. PMID: 18701504 Free PMC article.

7

Establishment of a dog model for the p53 family pathway and identification of a novel isoform of p21 cyclin-dependent kinase inhibitor.

Zhang J, Chen X, Kent MS, Rodriguez CO, Chen X. Zhang J, et al. Among authors: chen x. Mol Cancer Res. 2009 Jan;7(1):67-78. doi: 10.1158/1541-7786.MCR-08-0347. Mol Cancer Res. 2009. PMID: 19147538 Free PMC article.

8

Identification of GRO1 as a critical determinant for mutant p53 gain of function.

Yan W, Chen X. Yan W, et al. Among authors: chen x. J Biol Chem. 2009 May 1;284(18):12178-87. doi: 10.1074/jbc.M900994200. Epub 2009 Mar 3. J Biol Chem. 2009. PMID: 19258312 Free PMC article.

9

Characterization of functional domains necessary for mutant p53 gain of function.

Yan W, Chen X. Yan W, et al. Among authors: chen x. J Biol Chem. 2010 May 7;285(19):14229-38. doi: 10.1074/jbc.M109.097253. Epub 2010 Mar 8. J Biol Chem. 2010. PMID: 20212049 Free PMC article.

10

Mutant p53 protein is targeted by arsenic for degradation and plays a role in arsenic-mediated growth suppression.

Yan W, Zhang Y, Zhang J, Liu S, Cho SJ, Chen X. Yan W, et al. Among authors: chen x. J Biol Chem. 2011 May 20;286(20):17478-86. doi: 10.1074/jbc.M111.231639. Epub 2011 Mar 29. J Biol Chem. 2011. PMID: 21454520 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

117,652 results

Search Page

Filters